Akira Kitamura serves as the CEO of NEC Bio B.V. since March 2023 and holds the positions of Executive Chairperson and Chairperson & CEO at NEC OncoImmunity AS since July 2019. At NEC Corporation, Kitamura has been the General Manager of the AI Drug Development Division and has led the HealthTech Business Development Office, focusing on AI-based drug discovery and diagnostics, while also supporting the biotech venture CYTLIMIC Inc. Management experience includes corporate business development and innovation initiatives across various divisions within NEC and its subsidiaries. Kitamura has also contributed as a Board Member at CYTLIMIC Inc. and previously held roles in business development with NEC Corporation of America and Vodafone K.K. Kitamura's academic background includes a Bachelor's degree in History from Kansai University.
This person is not in any teams
This person is not in any offices